BioSyent Inc. (BIOYF)
OTCMKTS: BIOYF · Delayed Price · USD
7.31
+0.72 (10.94%)
Jul 22, 2024, 4:00 PM EDT - Market closed

Company Description

BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.

It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis.

In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; Combogesic to manage mild to moderate acute pain and reduction of fever in adults; and Proktis-M, a rectal suppository for the healing of the anus and rectum.

The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006.

BioSyent Inc. was founded in 2006 and is headquartered in Mississauga, Canada.

BioSyent Inc.
BioSyent logo
Founded 1947
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
CEO René C. Goehrum

Contact Details

Address:
2476 Argentia Road
Mississauga, ON L5N 6M1
Canada
Phone 905-206-0013
Website biosyent.com

Stock Details

Ticker Symbol BIOYF
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency CAD
ISIN Number CA0906901081

Key Executives

Name Position
René C. Goehrum Chairman, Chief Executive Officer and President
Robert J. March Vice President of Finance and Chief Financial Officer
Joost van der Mark Vice President of Corporate Development
Neelu Atwal Director of Human Resources
Alfred D'Souza Advisor